Skip to main content
SpringerLink
Log in

Economic analyses of aromatase inhibitors that are sponsored by pharmaceutical companies are less likely to report unfavourable results

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Jang S, Chae Y, Haddad T, Majhail NS.Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: A systematic review. 2009 Breast Cancer Symposium: abstr. 149, 08 Oct 2009. Available from: URL: http://www.asco.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Economic analyses of aromatase inhibitors that are sponsored by pharmaceutical companies are less likely to report unfavourable results. Pharmacoecon. Outcomes News 591, 13 (2009). https://doi.org/10.2165/00151234-200905910-00036

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905910-00036

Keywords

Search

Navigation